Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development, manufacturing, and distribution of traditional Chinese medicine and modern pharmaceuticals. Kangmei's core offerings include herbal extracts, health supplements, and innovative drug formulations, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including recognition for its advanced research and development capabilities, positioning it as a trusted name in the market. With a strong focus on integrating traditional practices with modern science, Kangmei continues to enhance its market presence and contribute to the global healthcare landscape.
DitchCarbon Score
How does Kangmei Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kangmei Pharmaceutical Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kangmei Pharmaceutical Co., Ltd.'s reported carbon emissions
Kangmei Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, Kangmei Pharmaceutical has not inherited any emissions data from a parent or related organization, nor does it have any commitments to the Science Based Targets initiative (SBTi) or other climate initiatives. This lack of data and commitments places the company in a context where it may need to enhance its climate strategy to align with industry standards and expectations for sustainability. In summary, Kangmei Pharmaceutical Co., Ltd. has not disclosed any carbon emissions or reduction initiatives, highlighting an opportunity for the company to develop and communicate its climate commitments more effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kangmei Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
